HomeTRUALT › Filing
🔔 Get instant alerts when TRUALT files quarterly results on BSE Start free trial →

Please find attached the outcome of the Board meeting held on September 22, 2026

Filed: 22 Sep 2026, 17:19 IST Exchange: BSE Category: Board Meeting — Appointment and Investment Approvals
Board meeting held on September 22, 2026 approved appointment of Dr. Sarvamangala R Patil as Additional Non-Executive Independent Woman Director, subject to shareholder approval. Approved additional investments of Rs. 21.42 crore in Leafiniti Bioenergy Pvt Ltd and Rs. 8.27 crore in TruAlt Sumi Gas Pvt Ltd, both subsidiaries. Draft postal ballot notice for director appointment and appointment of Scrutinizer and e-voting agency also approved.
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TRUALT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TRUALT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on TruAlt Bioenergy Limited

Important. The summary above is generated automatically from TruAlt Bioenergy Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.